financetom
Business
financetom
/
Business
/
DraftKings Insider Sold Shares Worth $15,895,848, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DraftKings Insider Sold Shares Worth $15,895,848, According to a Recent SEC Filing
May 26, 2025 7:27 AM

03:17 AM EDT, 05/14/2025 (MT Newswires) -- Matthew Kalish, Director, President - DraftKings ( DKNG ), North America, on May 09, 2025, sold 420,000 shares in DraftKings ( DKNG ) for $15,895,848. Following the Form 4 filing with the SEC, Kalish has control over a total of 4,354,377 Class A common shares of the company, with 4,155,130 shares held directly and 199,247 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1883685/000110465925048000/xslF345X05/tm2515014-4_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Redwire Plans to Appoint Chris Edmunds as Chief Financial Officer
Redwire Plans to Appoint Chris Edmunds as Chief Financial Officer
Oct 7, 2025
08:17 AM EDT, 10/07/2025 (MT Newswires) -- Redwire ( RDW ) said Tuesday it intends to appoint Chris Edmunds as chief financial officer, replacing Jonathan Baliff, who will retire, effective Nov. 30. Edmunds currently serves as the company's chief accounting officer. Baliff will serve as a consultant through December 2026, Redwire ( RDW ) said. The company's shares were up...
Fractyl Health Says Obesity Drug Candidate Shows Weight Loss in Preclinical Trial
Fractyl Health Says Obesity Drug Candidate Shows Weight Loss in Preclinical Trial
Oct 7, 2025
08:17 AM EDT, 10/07/2025 (MT Newswires) -- Fractyl Health ( GUTS ) said Tuesday that new preclinical data from its obesity candidate RJVA-002 showed 30% weight loss in mice after a single dose, with no adverse effects observed. The company said the study used a diet-induced obesity model with humanized GIP receptors and demonstrated a dose-dependent reduction in body weight...
Dye & Durham to Sell UK Unit Credas Technologies to SmartSearch for 77.8 Million Pounds
Dye & Durham to Sell UK Unit Credas Technologies to SmartSearch for 77.8 Million Pounds
Oct 7, 2025
08:18 AM EDT, 10/07/2025 (MT Newswires) -- Dye & Durham Limited ( DYNDF ) , a provider of cloud-based legal practice management software trading near 52 week lows, said Tuesday that it entered into a definitive agreement to sell Credas Technologies, a UK-based provider of identity verification and anti-money laundering solutions, to SmartSearch, an established UK provider of anti-money laundering...
Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models
Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models
Oct 7, 2025
08:17 AM EDT, 10/07/2025 (MT Newswires) -- Telomir Pharmaceuticals ( TELO ) said Tuesday that preclinical results show that its investigational therapy Telomir-1 reactivated two tumor suppressor genes, potentially preventing the spread of cancer and improving responses to chemotherapy. The results showed that the experimental therapy reactivated the MASPIN and RASSF1A genes through DNA methylation reset in prostate cancer models,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved